A detailed history of Marsico Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Marsico Capital Management LLC holds 21,390 shares of DXCM stock, worth $1.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
21,390
Previous 21,390 -0.0%
Holding current value
$1.5 Million
Previous $2.97 Million 18.24%
% of portfolio
0.08%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $2.44 Million - $3 Million
21,390 New
21,390 $2.97 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $3.38 Million - $6.6 Million
49,641 Added 174.82%
78,036 $5.82 Million
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $874,285 - $1.21 Million
-9,293 Reduced 24.66%
28,395 $14.5 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $20,649 - $25,888
159 Added 0.42%
37,688 $20.2 Million
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $1.46 Million - $1.94 Million
18,020 Added 92.37%
37,529 $16 Million
Q1 2021

May 17, 2021

SELL
$84.79 - $104.74 $3.05 Million - $3.77 Million
-35,955 Reduced 64.83%
19,509 $7.01 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $2.1 Million - $2.82 Million
-26,980 Reduced 32.73%
55,464 $20.5 Million
Q3 2020

Nov 13, 2020

BUY
$95.51 - $112.95 $6.62 Million - $7.82 Million
69,268 Added 525.71%
82,444 $34 Million
Q1 2020

May 15, 2020

BUY
$47.79 - $75.63 $190,825 - $301,990
3,993 Added 43.48%
13,176 $3.55 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $336,281 - $526,094
9,183 New
9,183 $2.01 Million
Q3 2017

Nov 14, 2017

SELL
$11.36 - $18.98 $378,447 - $632,299
-33,314 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
33,314
33,314 $2.44 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Marsico Capital Management LLC Portfolio

Follow Marsico Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marsico Capital Management LLC with notifications on news.